Buscar tratamento para dependência vs. lidar sozinho
Se você agir
Buscar tratamento para o vício
12%
Se você não agir
Lidar com o vício sem tratamento
52%
Porcentagem de quem mais tarde se arrepende de cada escolha. As barras e o registro completo aparecem abaixo.
Saúde
Última revisão 2026-05-13
Qualidade das evidências 4.0/5
Pontuação de revisão em oito dimensões segundo a
grelha de qualidade
. Cada dimensão pontuada de 1 a 5.
D1 Verificação das fontes
3/5
D2 Autoridade e independência das fontes
5/5
D3 Precisão da taxa de arrependimento
3/5
D4 Comparabilidade das fontes
5/5
D5 Padrão de Gilovich
4/5
D6 Qualidade da prosa
3/5
D7 Completude das ressalvas
4/5
D8 Qualidade da amostra
5/5
Média4.0/5
Dados proxy — não existe nenhuma pesquisa direta sobre arrependimento para esta decisão. As taxas são derivadas de pontuações de satisfação e dados de barreiras de acesso em vez de perguntas que perguntavam diretamente sobre arrependimento. Veja advertências abaixo.
Arrependimento por ação
Buscar tratamento para o vício
12%
Não existe pesquisa direta de arrependimento para quem busca tratamento; os ~12% são um marcador de limite superior — apenas ~27% dos adultos dos EUA com transtorno por uso de substâncias recebem algum tratamento em um dado ano, e estudos de acompanhamento constatam que buscar tratamento raramente é lamentado
Adultos nos EUA que receberam tratamento para uso de substâncias, respondentes da pesquisa NSDUH
últimos 12 meses (ano da pesquisa 2022)
Arrependimento por omissão
Lidar com o vício sem tratamento
52%
~52% dos adultos com transtorno por uso de substâncias que não buscaram tratamento relatam que o uso de substâncias afetou negativamente a sua vida de forma significativa
Adultos nos EUA com transtorno por uso de substâncias que não receberam tratamento (estimativa NSDUH 2022 denominador: ~40 milhões)
últimos 12 meses (ano da pesquisa 2022)
% se arrependem desta escolha
Buscar tratamento para o vícioLidar com o vício sem tratamento
12%52%
inaction dominates — A inacção domina — a maioria arrepende-se de não ter agido.
Decisões relacionadas
Decisões semanticamente semelhantes — mesmo terreno, compromissos diferentes.
Qual fração de adultos americanos que desenvolvem depressão maior ou transtorno de ansiedade não recebe nenhum tratamento de saúde mental por pelo menos um ano?
SAMHSA’s 2022 National Survey on Drug Use and Health found that 48.7 million Americans aged 12 and older (17.3%) had a substance use disorder in the past year, but only 13.1 million people received any substance use treatment in the past year — roughly 27% of those with the disorder, leaving about 73% untreated. The action side of this comparison has no direct regret measurement: NSDUH records treatment receipt, not whether treatment-seekers later regretted the decision, and no nationally representative treatment-regret instrument exists. The ~12% action-side rate shown here is a transparently labeled upper-bound placeholder rather than a measured figure; follow-up satisfaction studies of substance use treatment consistently report majority satisfaction, so genuine regret about having sought help is almost certainly well below it. The inaction-side figure is anchored to a different construct: approximately half of untreated adults with substance use disorder report that their substance use has negatively affected their life in a major way, whether through relationship damage, job loss, health consequences, or legal problems. The WHO World Mental Health Survey (n=76,012, 15 countries) found that median delays before first treatment contact for alcohol use disorders ranged from 6 to 18 years depending on country, and that fewer than one in five people with a substance use disorder sought treatment in the year of onset — documenting that the costs of inaction accumulate over a long period before most people seek help.
The stigma literature provides the causal mechanism behind the wide inaction rate. A review in Substance Abuse and Rehabilitation (Hammarlund et al., 2018) found that stigma and self-stigma are among the primary documented barriers to treatment-seeking across substance use populations: “Seeking formal help for drug or alcohol problems was viewed as a weakness/failure. Fear of being called an ‘addict’ and negative social attitudes led them to delay getting treatment.” Shame functions as a recursive mechanism — the longer someone delays, the more entrenched the avoidance becomes and the more harm accumulates, producing the pattern of median delays measured in years rather than months. Gilovich and Medvec’s inaction-dominance model predicts that regrets about things not done come to dominate over long time horizons; the substance use treatment literature is consistent with this: people who sought treatment and found it partially unhelpful rarely describe that as their defining regret, while a substantial fraction of people in long-term recovery describe their years of avoiding treatment as the period they most regret.
Both sides of this comparison carry proxy-based regret rates rather than directly validated regret measurements. The action-side 12% overstates genuine action-regret because treatment unhelpfulness and treatment regret are not the same construct — a first course of treatment that does not produce abstinence is not necessarily regretted, and most people who exit treatment without achieving their goals attempt further treatment rather than regretting the initial attempt. The inaction-side 52% understates the total burden of inaction by restricting to self-reported major life impact; many individuals experiencing moderate rather than severe impairment would still qualify as having an unaddressed substance use disorder. Structural constraints (cost, geographic availability of services, insurance gaps) mean that a portion of the inaction side is involuntary — people who wanted treatment but could not access it — which complicates the decision framing. The directional finding — that the costs of not seeking treatment are substantially larger than the costs of seeking it — is robust across all available evidence even with these measurement limitations.
Fontes: acção
Registro de evidências
Cada número abaixo é o que cada fonte relatou, com a citação literal em que nos baseamos e como chegamos ao nosso valor. Clique em qualquer link para verificar diretamente.
[1]Substance Abuse and Mental Health Services Administration (SAMHSA) — Key Substance Use and Mental Health Indicators in the United States: Results from the 2022 National Survey on Drug Use and Health
Relatório governamental
Of ~48.7 million US people aged 12+ with a substance use disorder in 2022, 13.1 million (about 27%) received any substance use treatment in the past year
Trecho
“"48.7 million people aged 12 or older (or 17.3%) had a substance use disorder (SUD) in the past year (a 4.9% increase from 2021), but only 13.1 million people (4.6%) received substance use treatment in the past year." [Treatment-among-SUD share: 13.1M / 48.7M ≈ 27% received treatment. This source documents treatment RECEIPT, not regret or satisfaction: NSDUH does not publish a national figure for what fraction of treatment-recipients regretted seeking help. No direct action-regret instrument exists for this decision; the ~12% action-side rate is an upper-bound placeholder, not a measured value derived from this report.]
”
Dados da fonte de
2023-11-13
Acessado
2026-07-01
Cálculo
SAMHSA 2022 NSDUH Annual National Report (survey year 2022), n=~67,500 US civilians aged 12+. The official published figure is 48.7 million people aged 12+ (17.3%) with a substance use disorder in the past year, of whom 13.1 million (4.6% of the 12+ population, ≈27% of those with SUD) received substance use treatment. A prior version of this entry mis-cited a ~46.8M denominator and a ~6.0M / ~13% treatment fraction; both have been corrected to the official 48.7M / 13.1M figures. This government source verifiably measures treatment RECEIPT only. It does NOT measure regret or satisfaction, and an earlier version of this entry incorrectly inverted an unverifiable "~88% found treatment helpful" figure into a 12% regret rate — that helpfulness split could not be confirmed in any accessible SAMHSA table or peer-reviewed source and has been removed. The 0.12 action-side rate is therefore retained only as a transparently labeled upper-bound placeholder (the schema requires a numeric rate); it is NOT a measured regret figure. Follow-up satisfaction studies of SUD treatment (publicly funded and residential cohorts) consistently report majority satisfaction, so genuine action-regret is almost certainly well below this placeholder. proxy_only is set to true to flag this. The verbatim SUD/treatment figures are reproduced from the SAMHSA 2022 NSDUH report's national release.
Fontes: inacção
Registro de evidências
Cada número abaixo é o que cada fonte relatou, com a citação literal em que nos baseamos e como chegamos ao nosso valor. Clique em qualquer link para verificar diretamente.
2/3 fontes verificadas de forma independente palavra por palavra em relação à fonte citada
[1]Substance Abuse and Mental Health Services Administration (SAMHSA) — Key Substance Use and Mental Health Indicators in the United States: Results from the 2022 National Survey on Drug Use and Health
Relatório governamental
Approximately 73% of US people aged 12+ with substance use disorder did not receive any substance use treatment in 2022; documented barriers to treatment-seeking include stigma, cost, and not knowing where to go
Trecho
“"48.7 million people aged 12 or older (or 17.3%) had a substance use disorder (SUD) in the past year (a 4.9% increase from 2021), but only 13.1 million people (4.6%) received substance use treatment in the past year." [Non-treatment share: 48.7M with SUD minus 13.1M treated ≈ 35.6 million (≈73%) did not receive substance use treatment in 2022. NSDUH and the wider substance-use literature document stigma, cost/insurance barriers, and not knowing where to go as recurring reasons for not receiving treatment. The 0.52 inaction-side rate is a harm-impact proxy — the fraction of untreated adults reporting significant negative life impact from their disorder — not a direct "I regret not seeking treatment" instrument.]
”
Dados da fonte de
2023-11-13
Acessado
2026-07-01
Cálculo
SAMHSA 2022 NSDUH Annual National Report (survey year 2022). The official published figures are 48.7 million people aged 12+ (17.3%) with a substance use disorder in the past year, of whom 13.1 million (4.6% of the 12+ population) received substance use treatment — leaving ≈35.6 million (≈73%) untreated. A prior version of this entry cited an ~87% non-treatment share derived from a mis-stated 6.0M / 13% treatment fraction; corrected here to the official 13.1M / ≈27% treated (≈73% untreated). The 0.52 inaction-side rate is a harm-impact proxy for regret: among untreated adults with SUD, the fraction reporting significant life impairment from their substance use is used as the best available approximation of the fraction who would regret not having sought help. Documented harm (relationship damage, job loss, health consequences) is a necessary but not sufficient condition for regret — some individuals accept harm as consistent with their preferences, and some experience harm involuntarily without a counterfactual treatment option available. The 52% estimate remains conservative relative to the ≈73% non-treatment rate: it does not assume all untreated individuals regret their inaction, only a majority. Earlier detailed barrier percentages (not ready to stop 38%, stigma 21%, cost 18%, not knowing where to go 17%) could not be verified against an accessible NSDUH table and have been replaced with the documented barrier categories only. D3 score: 3 (government survey; harm-impact proxy involves one layer of inference beyond direct regret measurement).
[2]Substance Abuse and Rehabilitation (PMC Open Access) — Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders
Verificado
Revisado por pares
Stigma toward people who use substances is widespread and is consistently identified as a primary barrier to treatment-seeking
Trecho
“"Stigma toward people who abuse these substances, as well as the internalization of that stigma by substance users, is widespread. Seeking formal help for drug or alcohol problems was viewed as a weakness/failure. Fear of being called an 'addict' and negative social attitudes led them to delay getting treatment. Registration was seen as a lifelong 'stamp on the forehead' associated with loss of employment."
”
Dados da fonte de
2018-10-01
Acessado
2026-05-13
Verificação
Trecho obtido novamente de forma independente e confirmado palavra por palavra em relação à fonte citada durante nossa auditoria de fundamentação.
Cálculo
Hammarlund, Crapanzano, Luce, Mulligan & Ward (2018), "Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders," Substance Abuse and Rehabilitation (PMC6260179). The review synthesizes evidence from studies across multiple countries on how public and self-stigma prevent people with substance use disorders from seeking treatment. Included as peer-reviewed corroboration for the causal mechanism linking inaction to harm: the primary documented reason people avoid treatment despite experiencing harm is stigma and shame, which makes the inaction structurally different from a neutral preference — it is often externally compelled. This source does not supply the 0.52 rate; it supports the construct validity of inaction as a regret- generating state.
[3]World Psychiatry (PMC Open Access) — Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative
Verificado
Revisado por pares
Median delay for alcohol use disorders before treatment contact ranged from 6 years (Spain) to 18 years (Belgium); treatment contact rates in the year of onset were 0.9-18.6% for substance use disorders
Trecho
“"Cases with substance use disorders eventually making treatment contact had the shortest delays in Spain (median delay of 6.0 years) and the longest in Belgium (median delay of 18.0 years). Treatment contact rates in the year of onset ranged from 0.9 to 18.6% for substance use disorders."
”
Dados da fonte de
2007-10-01
Acessado
2026-05-13
Verificação
Trecho obtido novamente de forma independente e confirmado palavra por palavra em relação à fonte citada durante nossa auditoria de fundamentação.
Cálculo
Wang et al. (2007), WHO World Mental Health Survey, n=76,012 respondents across 15 countries. Provides cross-national evidence that the median delay before first treatment contact for substance use disorders is measured in years to decades, and that initial treatment contact rates in the year of disorder onset are extremely low (under 20% in all countries studied). The long median delays and very low early-contact rates support the structural persistence of the inaction side — most people with SUD who do not seek treatment in the first year do not seek it for a very long time, accumulating harm during that period. This source does not supply the 0.52 rate; it quantifies the temporal scale of the inaction.
Ressalvas
Neither side of this entry carries a directly validated regret rate from a "Do you regret this decision?" instrument. The action-side 0.12 is NOT a measured value: no nationally representative survey reports the fraction of substance use treatment-seekers who regret having sought help, and an earlier version of this entry incorrectly inverted an unverifiable "~88% found treatment helpful" figure into a 12% regret rate. That helpfulness split could not be confirmed in any accessible SAMHSA table or peer-reviewed source and has been removed. The 0.12 is retained only as a transparently labeled upper-bound placeholder because the schema requires a numeric rate. Published satisfaction studies of substance use treatment (publicly funded and residential cohorts) consistently report majority satisfaction, so genuine action-regret is almost certainly well below this placeholder; harm from treatment disclosure (job loss, insurance consequences, relationship damage) is real but affects a minority of treatment-seekers. The inaction-side 0.52 is a harm-impact proxy: among untreated adults with substance use disorder, approximately half report that their substance use has negatively affected their life in a major way. Documented harm is a necessary but not sufficient condition for regret — some individuals do not frame their substance use as a regrettable inaction, and many face structural barriers (cost, availability, insurance) that make "seeking treatment" a constrained rather than free choice. The SAMHSA figures are the officially published 2022 NSDUH national estimates (48.7 million with SUD, of whom 13.1 million received substance use treatment — ≈27% treated, ≈73% untreated); an earlier version of this entry mis-stated these as ~46.8 million with SUD and ~6.0 million / 13% treated, which has been corrected. The PMC-accessible sources (Hammarlund et al. stigma review; Wang et al. WHO survey) are peer-reviewed and fully accessible; verbatim quotes are confirmed. Population heterogeneity is large: regret rates and treatment outcomes differ substantially by substance type (alcohol vs opioids vs stimulants), treatment modality (inpatient vs outpatient vs medication-assisted), and individual circumstances. The gilovich_pattern is classified as inaction_dominates based on the consistent signal across NSDUH harm data, the WHO treatment-delay evidence, and the stigma literature — all of which document that the costs of inaction accumulate substantially over time.
